These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 16231589

  • 1. The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis.
    Miele L, Forgione A, Hernandez AP, Gabrieli ML, Vero V, Di Rocco P, Greco AV, Gasbarrini G, Gasbarrini A, Grieco A.
    Eur Rev Med Pharmacol Sci; 2005; 9(5):273-7. PubMed ID: 16231589
    [Abstract] [Full Text] [Related]

  • 2. Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
    Miele L, Forgione A, Gasbarrini G, Grieco A.
    Transl Res; 2007 Mar; 149(3):114-25. PubMed ID: 17320797
    [Abstract] [Full Text] [Related]

  • 3. Non-alcoholic steatohepatitis in children.
    Nanda K.
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [Abstract] [Full Text] [Related]

  • 4. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
    Park SH.
    Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
    [Abstract] [Full Text] [Related]

  • 5. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, Miezyńska-Kurtycz J, Milkiewicz P.
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [Abstract] [Full Text] [Related]

  • 6. [Non-alcoholic fatty liver].
    Tagle Arrospide M.
    Rev Gastroenterol Peru; 2003 Jun; 23(1):49-57. PubMed ID: 12768215
    [Abstract] [Full Text] [Related]

  • 7. Metabolic disturbances in non-alcoholic fatty liver disease.
    Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH.
    Clin Sci (Lond); 2009 Apr; 116(7):539-64. PubMed ID: 19243311
    [Abstract] [Full Text] [Related]

  • 8. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course.
    Cortez-Pinto H, Camilo ME.
    Best Pract Res Clin Gastroenterol; 2004 Dec; 18(6):1089-104. PubMed ID: 15561640
    [Abstract] [Full Text] [Related]

  • 9. The epidemiology of nonalcoholic fatty liver disease in adults.
    Clark JM.
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S5-10. PubMed ID: 16540768
    [Abstract] [Full Text] [Related]

  • 10. Nonalcoholic fatty liver disease.
    Yu AS, Keeffe EB.
    Rev Gastroenterol Disord; 2002 Mar; 2(1):11-9. PubMed ID: 12122975
    [Abstract] [Full Text] [Related]

  • 11. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM.
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [Abstract] [Full Text] [Related]

  • 12. [Nonalcoholic steatohepatitis. Three case reports].
    Eivindson MV, Hamilton-Dutoit S, Grønbaek H.
    Ugeskr Laeger; 2003 Mar 10; 165(11):1118-20. PubMed ID: 12677986
    [Abstract] [Full Text] [Related]

  • 13. Nonalcoholic fatty liver disease as a complication of insulin resistance.
    Abdelmalek MF, Diehl AM.
    Med Clin North Am; 2007 Nov 10; 91(6):1125-49, ix. PubMed ID: 17964913
    [Abstract] [Full Text] [Related]

  • 14. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM, Flancbaum L, Machan JT, Charney DA, Kotler DP.
    Am J Gastroenterol; 2007 Feb 10; 102(2):399-408. PubMed ID: 17311652
    [Abstract] [Full Text] [Related]

  • 15. Nonalcoholic fatty liver disease.
    Angulo P.
    Rev Gastroenterol Mex; 2005 Nov 10; 70 Suppl 3():52-6. PubMed ID: 17471859
    [Abstract] [Full Text] [Related]

  • 16. Recent concepts in non-alcoholic fatty liver disease.
    Adams LA, Angulo P.
    Diabet Med; 2005 Sep 10; 22(9):1129-33. PubMed ID: 16108837
    [Abstract] [Full Text] [Related]

  • 17. Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease.
    Haukeland JW, Konopski Z, Linnestad P, Azimy S, Marit Løberg E, Haaland T, Birkeland K, Bjøro K.
    Scand J Gastroenterol; 2005 Dec 10; 40(12):1469-77. PubMed ID: 16293559
    [Abstract] [Full Text] [Related]

  • 18. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations.
    Preiss D, Sattar N.
    Clin Sci (Lond); 2008 Sep 10; 115(5):141-50. PubMed ID: 18662168
    [Abstract] [Full Text] [Related]

  • 19. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Harrison SA, Neuschwander-Tetri BA.
    Clin Liver Dis; 2004 Nov 10; 8(4):861-79, ix. PubMed ID: 15464659
    [Abstract] [Full Text] [Related]

  • 20. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma.
    Cuadrado A, Orive A, García-Suárez C, Domínguez A, Fernández-Escalante JC, Crespo J, Pons-Romero F.
    Obes Surg; 2005 Mar 10; 15(3):442-6. PubMed ID: 15826485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.